These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34779760)

  • 21. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
    Prymula R
    Vaccine; 2009 Jul; 27(35):4739-40. PubMed ID: 19540951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model.
    Ogunniyi AD; LeMessurier KS; Graham RM; Watt JM; Briles DE; Stroeher UH; Paton JC
    Infect Immun; 2007 Apr; 75(4):1843-51. PubMed ID: 17261599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pneumococcus: why a commensal misbehaves.
    Weiser JN
    J Mol Med (Berl); 2010 Feb; 88(2):97-102. PubMed ID: 19898768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
    Pletz MW; Maus U; Krug N; Welte T; Lode H
    Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonencapsulated Streptococcus pneumoniae: Emergence and Pathogenesis.
    Keller LE; Robinson DA; McDaniel LS
    mBio; 2016 Mar; 7(2):e01792. PubMed ID: 27006456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Streptococcus pneumoniae: virulence factors and variation.
    Mitchell AM; Mitchell TJ
    Clin Microbiol Infect; 2010 May; 16(5):411-8. PubMed ID: 20132250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease.
    Cockeran R; Anderson R; Feldman C
    Arch Immunol Ther Exp (Warsz); 2005; 53(3):189-98. PubMed ID: 15995579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging concepts in the pathogenesis of the Streptococcus pneumoniae: From nasopharyngeal colonizer to intracellular pathogen.
    Subramanian K; Henriques-Normark B; Normark S
    Cell Microbiol; 2019 Nov; 21(11):e13077. PubMed ID: 31251447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divergent serotype distribution between children with otitis media and those without in the pneumococcal conjugate vaccine era.
    Chen CH; Chen CL; Arguedas A; Southern J; Hsiao CC; Chiu CH
    J Microbiol Immunol Infect; 2020 Dec; 53(6):1035-1038. PubMed ID: 32475800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pneumococcal Vaccines - How Many Serotypes are Enough?
    Singh A; Dutta AK
    Indian J Pediatr; 2018 Jan; 85(1):47-52. PubMed ID: 28887787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New vaccines for the prevention of pneumococcal infections.
    Käyhty H; Eskola J
    Emerg Infect Dis; 1996; 2(4):289-98. PubMed ID: 8969245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transforming Streptococcus pneumoniae in the 21st century.
    Hsieh YC; Lee WS; Shao PL; Chang LY; Huang LM
    Chang Gung Med J; 2008; 31(2):117-24. PubMed ID: 18567411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge.
    Zhang Y; Masi AW; Barniak V; Mountzouros K; Hostetter MK; Green BA
    Infect Immun; 2001 Jun; 69(6):3827-36. PubMed ID: 11349048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pneumococcal vaccines: do they prevent infection and how?
    Posfay-Barbe KM; Wald ER
    Curr Opin Infect Dis; 2004 Jun; 17(3):177-84. PubMed ID: 15166818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution and annual changes in the proportion of Streptococcus pneumoniae serotypes in Japanese adults with pneumococcal pneumonia from 2011 to 2017.
    Noguchi S; Yatera K; Akata K; Chang B; Ikegami H; Hata R; Yamasaki K; Kawanami T; Mukae H
    J Infect Chemother; 2019 Nov; 25(11):925-929. PubMed ID: 31350184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammasomes in Pneumococcal Infection: Innate Immune Sensing and Bacterial Evasion Strategies.
    Rabes A; Suttorp N; Opitz B
    Curr Top Microbiol Immunol; 2016; 397():215-27. PubMed ID: 27460812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Epidemiology and Biostatistics of Pneumococcus.
    Oligbu G; Fry NK; Ladhani SN
    Methods Mol Biol; 2019; 1968():215-224. PubMed ID: 30929218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Streptococcus pneumoniae infection: a Canadian perspective.
    Deng X; Church D; Vanderkooi OG; Low DE; Pillai DR
    Expert Rev Anti Infect Ther; 2013 Aug; 11(8):781-91. PubMed ID: 23977934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etiology of acute otitis media and phenotypic-molecular characterization of Streptococcus pneumoniae isolated from children in Liuzhou, China.
    Fu J; Li L; Liang Z; Xu S; Lin N; Qin P; Ye X; McGrath E
    BMC Infect Dis; 2019 Feb; 19(1):168. PubMed ID: 30770718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging invasive nonvaccine pneumoccocal serotype 25.
    Al Waili BR; Alola S; Albanyan E
    Ann Saudi Med; 2013; 33(4):392-3. PubMed ID: 22750771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.